DUGGAN ROBERT W — SEC insider filings

SEC reporting owner CIK 1055919. 55 insider filings on record with FilingPulse; latest filed 2026-11-20.

Transaction summary — filings shown

Covers the 50 most recent of 55 filings on record, filed 2021-07-02 to 2026-11-20. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Summit Therapeutics Inc. (SMMT)Co-Chief Executive Officer, Director, 10% owner177 legs · 475,614,157 sh · $545,250,040—19
PULSE BIOSCIENCES, INC. (PLSE)Director, 10% owner3326 legs · 15,778,737 sh · $156,283,093—58

Insider filings — DUGGAN ROBERT W

FiledFormIssuerReported transactionsSource
2026-11-204Summit Therapeutics Inc. (SMMT)Option exercise (M): 300,000 @ $1.06 · Option exercise (M): 300,000 (derivative) @ $0EDGAR
2026-11-164Summit Therapeutics Inc. (SMMT)Option exercise (M): 500,000 @ $1.06 · Option exercise (M): 500,000 (derivative) @ $0EDGAR
2026-06-154PULSE BIOSCIENCES, INC. (PLSE)Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 12,495 (derivative) @ $0EDGAR
2026-06-124Summit Therapeutics Inc. (SMMT)Purchase (P): 3,810,000 @ $13.12EDGAR
2026-06-044Summit Therapeutics Inc. (SMMT)Purchase (P): 100,000 @ $14.60EDGAR
2026-05-154/APULSE BIOSCIENCES, INC. (PLSE)Purchase (P): 660,233 @ $19.69EDGAR
2026-05-114PULSE BIOSCIENCES, INC. (PLSE)Purchase (P): 660,233 @ $19.69EDGAR
2026-01-064Summit Therapeutics Inc. (SMMT)Grant/award (A): 11,232 (derivative) @ $8.76EDGAR
2025-10-234Summit Therapeutics Inc. (SMMT)Grant/award (A): 13,980,789 @ $18.74 · Grant/award (A): 266,808 @ $18.74 · Purchase (P): 26,680 @ $18.74EDGAR
2025-09-124PULSE BIOSCIENCES, INC. (PLSE)Purchase (P): 34,659 @ $14.66 · Purchase (P): 12,800 @ $14.77 · Purchase (P): 145,140 @ $14.41EDGAR
2025-09-114Summit Therapeutics Inc. (SMMT)Purchase (P): 333,394 @ $17.68 · Purchase (P): 5,000 @ $18.07EDGAR
2025-08-194PULSE BIOSCIENCES, INC. (PLSE)Grant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 20,792 (derivative) @ $0EDGAR
2025-06-024Summit Therapeutics Inc. (SMMT)Option exercise (M): 74,545 @ $2.64 · Option exercise (M): 74,545 (derivative) @ $0EDGAR
2025-05-014Summit Therapeutics Inc. (SMMT)Grant/award (A): 1,040,000 (derivative) · Grant/award (A): 400,000 (derivative) · Grant/award (A): 9,590,558 (derivative)EDGAR
2025-04-094Summit Therapeutics Inc. (SMMT)Option exercise/expiry (X): 3,985,055 @ $1.58 · Option exercise/expiry (X): 3,985,055 (derivative) @ $0EDGAR
2025-01-064Summit Therapeutics Inc. (SMMT)Grant/award (A): 10,724 (derivative) @ $9.18EDGAR
2024-12-184PULSE BIOSCIENCES, INC. (PLSE)Option exercise/expiry (X): 5,187,824 @ $11 · Option exercise/expiry (X): 69,020 @ $11 · Option exercise/expiry (X): 49,312 @ $11 · Option exercise/expiry (X): 2,593,912 (derivative) · Option exercise/expiry (X): 2,593,912 (derivative) · Option exercise/expiry (X): 34,510 (derivative) · +3 moreEDGAR
2024-12-174PULSE BIOSCIENCES, INC. (PLES)Purchase (P): 45,404 @ $17.13EDGAR
2024-12-174PULSE BIOSCIENCES, INC. (PLSE)Purchase (P): 55,256 @ $17.18EDGAR
2024-12-134PULSE BIOSCIENCES, INC. (PLSE)Purchase (P): 6,054 @ $16.74 · Purchase (P): 50,000 @ $17.42EDGAR
2024-09-134Summit Therapeutics Inc. (SMMT)Grant/award (A): 3,325,991 @ $22.70EDGAR
2024-07-094PULSE BIOSCIENCES, INC. (PLSE)Option exercise/expiry (X): 5,187,824 · Option exercise/expiry (X): 69,020 · Option exercise/expiry (X): 49,312 · Purchase (P): 2,593,912 (derivative) · Purchase (P): 2,593,912 (derivative) · Purchase (P): 34,510 (derivative) · +3 moreEDGAR
2024-06-244Pulse Biosciences, Inc. (PLSE)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 16,247 (derivative) @ $0EDGAR
2024-01-044Summit Therapeutics Inc. (SMMT)Grant/award (A): 74,545 (derivative) @ $1.32EDGAR
2023-12-144Pulse Biosciences, Inc. (PLSE)Purchase (P): 17,999 @ $9.15EDGAR
2023-12-134Pulse Biosciences, Inc. (PLSE)Purchase (P): 90,118 @ $9.36EDGAR
2023-12-124Pulse Biosciences, Inc. (PLSE)Purchase (P): 116,656 @ $9.54EDGAR
2023-12-114Pulse Biosciences, Inc. (PLSE)Purchase (P): 74,852 @ $9.19EDGAR
2023-12-084Pulse Biosciences, Inc. (PLSE)Option exercise (M): 9,933 @ $5.95 · Purchase (P): 82,813 @ $9.06 · Option exercise (M): 9,933 (derivative) @ $0EDGAR
2023-12-074Pulse Biosciences, Inc. (PLSE)Purchase (P): 66,021 @ $9.34EDGAR
2023-12-064Pulse Biosciences, Inc. (PLSE)Option exercise (M): 20,000 @ $10.66 · Option exercise (M): 20,347 @ $10.66 · Purchase (P): 27,000 @ $10.38 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 20,347 (derivative) @ $0EDGAR
2023-12-054Pulse Biosciences, Inc. (PLSE)Purchase (P): 45,600 @ $9.07EDGAR
2023-12-044Pulse Biosciences, Inc. (PLSE)Purchase (P): 152,944 @ $9.06EDGAR
2023-12-014Pulse Biosciences, Inc. (PLSE)Option exercise (M): 1,667 @ $5.95 · Purchase (P): 158,600 @ $9.44 · Purchase (P): 60,000 @ $9.21 · Option exercise (M): 1,667 (derivative) @ $0EDGAR
2023-11-304Pulse Biosciences, Inc. (PLSE)Purchase (P): 124,397 @ $8.98EDGAR
2023-11-204Pulse Biosciences, Inc. (PLSE)Purchase (P): 241 @ $6.10 · Purchase (P): 10,000 @ $6.09 · Purchase (P): 10,000 @ $6.11EDGAR
2023-11-094Pulse Biosciences, Inc. (PLSE)Option exercise (M): 3,333 @ $5.95 · Option exercise (M): 9,932 @ $5.95 · Option exercise (M): 3,333 (derivative) @ $0 · Option exercise (M): 9,932 (derivative) @ $0EDGAR
2023-08-284Pulse Biosciences, Inc. (PLSE)Option exercise (M): 1,667 @ $5.95 · Option exercise (M): 1,667 (derivative) @ $0EDGAR
2023-07-274Pulse Biosciences, Inc. (PLSE)Option exercise (M): 1,667 @ $5.95 · Option exercise (M): 1,667 (derivative) @ $0EDGAR
2023-07-074Pulse Biosciences, Inc. (PLSE)Option exercise (M): 65,000 @ $2.14 · Option exercise (M): 65,467 @ $2.14 · Option exercise (M): 1,666 @ $5.95 · Option exercise (M): 65,000 (derivative) @ $0 · Option exercise (M): 65,467 (derivative) @ $0 · Option exercise (M): 1,666 (derivative) @ $0EDGAR
2023-06-164Pulse Biosciences, Inc. (PLSE)Option exercise/expiry (X): 5,683,163 @ $2.05 · Option exercise/expiry (X): 81,025 @ $2.05 · Option exercise/expiry (X): 5,683,163 (derivative) @ $0 · Option exercise/expiry (X): 81,025 (derivative) @ $0EDGAR
2023-06-064Pulse Biosciences, Inc. (PLSE)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 39,731 (derivative) @ $0EDGAR
2023-05-104Pulse Biosciences, Inc. (PLSE)Purchase (P): 10,022,937 @ $6.51EDGAR
2023-03-084Summit Therapeutics Inc. (SMMT)Purchase (P): 376,489,880 @ $1.05EDGAR
2022-12-084Summit Therapeutics Inc. (SMMT)Other (J): 9,346,434EDGAR
2022-08-184Summit Therapeutics Inc. (SMMT)Purchase (P): 94,849,203 @ $0.97EDGAR
2022-06-104Pulse Biosciences, Inc. (PLSE)Option exercise/expiry (X): 5,683,163 · Option exercise/expiry (X): 81,025 · Purchase (P): 5,683,163 (derivative) · Purchase (P): 81,025 (derivative)EDGAR
2022-05-254Summit Therapeutics Inc. (SMMT)Other (J): 21,135EDGAR
2022-05-234Pulse Biosciences, Inc. (PLSE)Grant/award (A): 20,000 (derivative) @ $0 · Grant/award (A): 110,467 (derivative) @ $0EDGAR
2021-07-024Pulse Biosciences, Inc. (PLSE)Purchase (P): 3,048,780 @ $16.40EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-10 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1055919 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs